We found that DOC was not elevated in the patients with non-liver diseases analyzed here, and it was still insensitive as biomarker in AMI patients where ALT is easily increased, but there may be other diseases or conditions where DOC can be elevated in the absence of liver disease. This evidence concerns the gene GPT and liver disorder.